Adequan - Multi-Dose Vial

Details

Adequan^® i.m. (polysulfated glycosaminoglycan) is recommended for the intramuscular treatment of non-infectious degenerative and/or traumatic joint dysfunction and associated lameness of the carpal and hock joints in horses.

As the only FDA-Approved equine PSGAG, Adequan^® i.m. has a mode of action that helps treat degenerative joint disease (DJD) in multiple ways to keep joints moving. It is proven to help:

Reduce the swelling and inflammation associated with joint disease to improve lameness

Restore synovial lubrication that facilitates movement and reduces local inflammation
Repair cartilage and rapidly aid in the production of new cartilage
Reverse the disease cycle that leads the loss of cartilage components by inhibiting harmful enzymes that attack cartilage and synovial fluid

Reviews

Write Your Own Review

Adequan - Multi-Dose Vial - 50ml